FORT LAUDERDALE, FL / ACCESSWIRE / August 19, 2024 / Sunshine Biopharma, Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology and antivirals today announced that it has filed its 2024 second quarter report with the Securities and Exchange Commission. The Company reported gross revenues of $9,303,067 for the three months ended June 30, 2024, a 67% increase over gross revenues of $5,560,865 for same period in 2023.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| BZ Brandon Zatopek Commonwealth Equity Services LLC | 181,591 | $6.41M | $6.24M | -$176,840.49 | -2.76% |
| NASDAQ (NMS) Exchange | US Country |
This fund primarily focuses on investing in securities that form part of the Nasdaq-100 Quarterly Protective Put 90 Index. The core of its investment strategy involves allocating at least 80% of its total assets into the securities that are directly linked with the aforementioned underlying index. The underlying index itself is designed to track the performance of a specific risk management approach. This approach combines holding the underlying stocks of the NASDAQ 100® Index with a protective put strategy. Protective puts involve purchasing put options on the NASDAQ 100® Index to hedge against potential market downturns. This method aims at providing a safety net against declines in the index’s value, thereby offering a level of protection to the fund's portfolio. It's important to note that this fund opts for a non-diversified investment approach, implying that it may concentrate its investments in fewer securities than a diversified fund.
The fund invests predominantly in securities that are part of the Nasdaq-100 Quarterly Protective Put 90 Index. This significant allocation is central to the fund's investment strategy, leveraging the index's performance which is based on applying a protective put strategy to the components of the NASDAQ 100® Index.
A protective put strategy constitutes a critical aspect of the fund's approach to risk management. By purchasing put options on the NASDAQ 100® Index, the fund seeks to protect its investments against significant market drops. This strategy is designed to mitigate losses by enabling the fund to sell its holdings at predetermined prices, despite potential declines in the market value of these investments.